cellestia-biotech-employee

Dr. Renata Ferrarotto

Clinical Advisory Board Member

Renata Ferrarotto is an Assistant Professor and the Director of the Head and
Neck Clinical Research Program at MD Anderson Cancer Center, Houston,
Texas. Dr. Ferrarotto’s work focuses on the clinical development of new
therapeutic strategies for patients with head and neck malignancies and novel
methods for prediction and evaluation of treatment effect and improvement in
patients` quality of life, driven by solid background scientific data, thus
contributing to the advancement of personalized cancer therapy. She has an
interest in rarer head and neck tumor subtypes, particularly salivary gland
carcinomas. She has conceived, developed, and led a project to investigate the
significance of NOTCH1 mutations in adenoid cystic carcinoma (ACC) and has
received a Conquer Cancer Career Development Award and a Khalifa Scholar
Grant to continue her work investigating Notch1 as a promising therapeutic target
in ACC. Renata is a member of various oncology organizations and societies:
ASCO (American Society of Clinical Oncology), SWOG (Southwest Oncology
Group), NASBS (North America Skull base Society), and IRCI (International Rare
Cancers initiative).
Linkedin Profile